Offshore wind technology developer Principle received funding from Tokyo Gas, which joined existing investors including EDP Ventures, Repsol and ASM Industries.

Atom Bioscience will use the capital from the series B round, which was co-led by Livzon Pharmaceutical, to advance its gout treatment into phase 2 trials.

Blue Venture Fund and McKesson Ventures returned to reinvest in the cancer care analysis platform through a round that almost doubled its overall funding.

Ride hailing service Ola has pulled in $26.7m for its financial services offshoot from Falcon Edge, Matrix Partners and Apoletto Managers at a $250m valuation.

Babylon Health led a series B round for the healthcare measurement kiosk provider that also featured Rush University Medical Center for Health.

CRUK and Cambridge precision cancer diagnostics spinout Inivata has secured $25m from NeoGenomics as part of a deal that includes an acquisition option.

Cancer diagnostics technology developer Inivata has secured $25m from NeoGenomics to take its total funding to more than $128m.

Truework, which provides software to run employment and income background checks, secured the return of Sequoia Capital and Khosla Ventures to bring its total to $45m.

Poste Italiane has taken part in a $27.2m round for the last-mile delivery service having already launched a strategic partnership in January.

Clara, an insurance data software provider that counts NewYork-Presbyterian among its investors has added series B funding that will support recruitment.